These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9085459)

  • 21. Catch up in bone acquisition in young adult men with late normal puberty.
    Darelid A; Ohlsson C; Nilsson M; Kindblom JM; Mellström D; Lorentzon M
    J Bone Miner Res; 2012 Oct; 27(10):2198-207. PubMed ID: 22653693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
    Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
    Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density in Iranian patients with inflammatory bowel disease.
    Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
    Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral content of femoral bone and the lumbar spine measured in women with fracture of the femoral neck by dual photon absorptiometry.
    Bohr H; Schaadt O
    Clin Orthop Relat Res; 1983 Oct; (179):240-5. PubMed ID: 6617023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density in patients with type 1 diabetes mellitus.
    Rozadilla A; Nolla JM; Montaña E; Fiter J; Gómez-Vaquero C; Soler J; Roig-Escofet D
    Joint Bone Spine; 2000; 67(3):215-8. PubMed ID: 10875321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of mineral status and glucocorticoid use on bone mineral density in patients with Crohn's disease.
    Pierote NR; Braz AF; Barros SL; Moita Neto JM; Parente JML; Silva MDCM; Beserra MS; Soares NRM; Marreiro DN; do Noscimento Nogueira N
    Nutrition; 2018 Apr; 48():13-17. PubMed ID: 29469014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
    Dubois EF; Röder E; Dekhuijzen PN; Zwinderman AE; Schweitzer DH
    Chest; 2002 May; 121(5):1456-63. PubMed ID: 12006428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease.
    von Tirpitz C; Epp S; Klaus J; Mason R; Hawa G; Brinskelle-Schmal N; Hofbauer LC; Adler G; Kratzer W; Reinshagen M
    Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1165-70. PubMed ID: 14560148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease of trabecular bone score reflects severity of Crohn's disease: results of a case-control study.
    Krajcovicova A; Kuzma M; Hlavaty T; Hans D; Koller T; Jackuliak P; Leskova Z; Sturdik I; Killinger Z; Payer J
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):101-106. PubMed ID: 29064848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy.
    Tobias JH; Sasi MR; Greenwood R; Probert CS
    Aliment Pharmacol Ther; 2004 Nov; 20(9):951-7. PubMed ID: 15521842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
    Marciniak C; Gabet J; Lee J; Ma M; Brander K; Wysocki N
    Osteoporos Int; 2016 Apr; 27(4):1477-1484. PubMed ID: 26576540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body composition by dual-energy X-ray absorptiometry in patients with Crohn's disease.
    Tjellesen L; Nielsen PK; Staun M
    Scand J Gastroenterol; 1998 Sep; 33(9):956-60. PubMed ID: 9759952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
    Soo I; Siffledeen J; Siminoski K; McQueen B; Fedorak RN
    J Crohns Colitis; 2012 Aug; 6(7):777-86. PubMed ID: 22398088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pediatric Bone Mass Scan has Poor Ability to Predict Peak Bone Mass: An 11-Year Prospective Study in 121 Children.
    Buttazzoni C; Rosengren BE; Karlsson C; Dencker M; Nilsson JÅ; Karlsson MK
    Calcif Tissue Int; 2015 May; 96(5):379-88. PubMed ID: 25716719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal bone mineral content and density in Rett syndrome and their contributing factors.
    Jefferson A; Fyfe S; Downs J; Woodhead H; Jacoby P; Leonard H
    Bone; 2015 May; 74():191-8. PubMed ID: 25659951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease.
    Lamb EJ; Wong T; Smith DJ; Simpson DE; Coakley AJ; Moniz C; Muller AF
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1895-902. PubMed ID: 12390098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Musculoskeletal health in newly diagnosed children with Crohn's disease.
    Ward LM; Ma J; Rauch F; Benchimol EI; Hay J; Leonard MB; Matzinger MA; Shenouda N; Lentle B; Cosgrove H; Scharke M; Konji VN; Mack DR
    Osteoporos Int; 2017 Nov; 28(11):3169-3177. PubMed ID: 28791436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal study of bone mineral density in patients with Crohn's disease.
    de Jong DJ; Mannaerts L; van Rossum LG; Corstens FH; Naber AH
    Dig Dis Sci; 2003 Jul; 48(7):1355-9. PubMed ID: 12870795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.